Healthcare / Medical Care FacilitiesParis
$11.10
-0.20 (-1.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $426.7M · quality 33.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.2B
P/E
N/A
•EV/EBITDA
8.2x
↓ROE
-4.7%
↓Gross Margin
77.9%
↑Debt/Equity
3.57
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.8%
FCF CAGR
+100.0%
FCF margin
10.5%
FCF / Net income
-10.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.24B · net income $-54.1M · FCF $550.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.24B | $5.24B | $5.01B | $4.70B | $4.30B |
| Net Income | $-54.1M | $-54.1M | $-53.9M | $49.4M | $118.4M |
| EBITDA | $599.7M | $599.7M | $562.9M | $645.6M | $677.1M |
| EPS | — | — | -0.49 | 0.45 | 1.07 |
| Gross Margin | 77.9% | 77.9% | 78.7% | 79.2% | 79.3% |
| Operating Margin | 3.6% | 3.6% | 3.7% | 4.7% | 6.8% |
| Net Margin | -1.0% | -1.0% | -1.1% | 1.1% | 2.8% |
| Balance Sheet | |||||
| Debt/Equity | 3.57 | 3.57 | 3.40 | 3.33 | 3.27 |
| Current Ratio | 0.77 | 0.77 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $550.9M | $550.9M | $418.3M | $426.7M | $68.9M |
| Returns | |||||
| ROE | -4.7% | -4.7% | -4.5% | 4.0% | 9.8% |
| Valuation | |||||
| P/E | — | — | — | 45.33 | 20.93 |
| EV/EBITDA | 8.24 | 8.24 | 9.68 | 9.37 | 9.31 |
| P/B | 1.07 | 1.07 | 1.46 | 1.81 | 2.04 |
| Growth & Yield | |||||
| Revenue Growth | 4.7% | 4.7% | 6.5% | 9.3% | — |
| EPS Growth | — | — | -208.9% | -57.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.49 → n/d
Residual
+2.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.